Business Context and Reporting Period
This Form 6-K filing by GSK plc, dated July 18, 2022, announces the completion of the demerger of its Consumer Healthcare business to form the Haleon Group. The filing also details the concurrent consolidation of GSK shares approved by shareholders on July 6, 2022.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate restructuring events and share capital mechanics.
- Issued Share Capital: 5,389,096,045 ordinary shares of 25 pence each (as of the announcement time).
- Treasury Shares: 304,905,950 ordinary shares held in treasury.
- Total Voting Rights: 5,084,190,095.
- Share Consolidation Ratio: Not fixed at the time of filing; dependent on share volume and price fluctuations between 8:00 a.m. and 4:30 p.m. on July 18, 2022.
Material Changes
The primary material change is the structural separation of the Consumer Healthcare business into a new independent entity, Haleon plc. Additionally, GSK is undergoing a share consolidation which will alter the number of outstanding shares and the nominal value per share, though the total market capitalization is intended to remain consistent.
Guidance, Outlook, and Risks
Outlook and Timetable:
- Haleon shares commenced trading on the London Stock Exchange (LSE) on July 18, 2022.
- Haleon ADSs are expected to trade on a "when-issued" basis on the NYSE starting July 18, 2022, with regular-way trading commencing July 22, 2022.
- New GSK shares are expected to commence dealings on the LSE on July 19, 2022.
- Definitive share certificates and statements are expected to be dispatched by early August 2022.
- Forward-looking statements are subject to risks including those described in the 2021 Form 20-F, Q1 2022 results, and impacts of the COVID-19 pandemic.
- The share consolidation ratio is contingent on market fluctuations on the day of the announcement.
- Timetable dates are indicative and subject to change without notice.
Investor Verification Checklist
- Verify the final GSK share consolidation ratio once announced by the company.
- Confirm the commencement of regular-way trading for Haleon ADSs on the NYSE on July 22, 2022.
- Monitor the receipt of definitive share certificates or CSN statements by the August 1, 2022 deadline.
- Review the Circular to Shareholders published on June 1, 2022, for detailed terms of the demerger.